Home » Topics » BioWorld Science

BioWorld Science
RSS

BXT-51072 in phase I clinical trials

Aug. 16, 1996

U.S. patent reinforces OraVax's UreAB development position

Aug. 16, 1996

Novopharm states intention to market generic ranitidine

Aug. 16, 1996

Glaxo Wellcome fights Novopharm attempt to market generic ranitidine

Aug. 16, 1996

U.S. patent granted for (S)-oxybutynin

Aug. 16, 1996

Sepracor to develop (S)-doxazosin for BPH; U.S. patent granted

Aug. 16, 1996

Sanofi describes fibrinogen antagonists

Aug. 16, 1996

Fibrinogen antagonists claimed by Toyama

Aug. 16, 1996

SKB reports fibrinogen antagonists

Aug. 16, 1996

Anticoagulant hirudin analogue NF-22 designated developmental candidate

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...